Christopher Anzalone, Ph.D., president and chief executive officer
Javier San Martin, M.D., Chief Medical Officer
Ken Myszkowski, MBA, CPA, chief financial officer
James Hamilton, M.D., MBA, Chief Discovery and Translational Medicine
Revenue
$243.2 million(2022)[1]
Number of employees
376
Website
arrowheadpharma.com
Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action.[2][3] The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.[2] The company has sixteen products in its pipeline, in various stages of development.[2]
Product
Indication
Development phase
Notes
ARO-HBV[2]
Hepatitis B
In clinic, phase 2
Licensed with Janssen, Phase 2
ARO-AAT[2]
Alpha-1 antirypsin deficiency
In clinic, phase 3
Orphan Drug designation, partnered with Takeda
ARO-APOC3[2]
Hypertriglyceridemia
Phase 2, 3
Orphan Drug designation, Fast Track Designation, Phase 3 for FCS, Phase 2 for expanded populations
ARO-HIF2[2]
Renal cell carcinoma
Preclinical
Second generation being worked on presumably
ARO-ENaC[2]
Cystic fibrosis
Preclinical
Second generation being worked on in preclinic
ARO-ANG3[2]
Dyslipidemia
In clinic, Phase 2
Orphan Drug designation
Olpasiran/ AMG 890[2]
Cardiovascular disease
In clinic, phase 3
Partnered with Amgen
ARO-PNPLA3
NASH
In clinic, Phase 1
License returned to ARWR
ARO-HSD
NASH
In clinic, Phase 1
Licensed to GSK
ARO-C3
Complement Mediated Disease
In clinic, Phase 1
ARO-MUC5AC
Muco-obstructive
In clinic, Phase 1
ARO-RAGE
Inflammatory
In clinic, Phase 1
ARO-MMP7
Idiopathic Pulmonary Fibrosis
In clinic, Phase 1
ARO-COV
Covid-19
Preclinical
ARO-DUX4
FSHD
Preclinical
HZN-457
Gout
In clinic, Phase 1
Partnered with Horizon
In 2015, the company substantially expanded its intellectual property holdings through complete acquisition of the full RNAi research and development portfolio, and assets from Novartis.[4][5]
In April 2016, it was announced that the former company name, Arrowhead Research Corporation, will be changed to Arrowhead Pharmaceuticals, Inc.[6]
In September 2016, Arrowhead entered into two collaboration and licensing agreements with Amgen. Under the deals, Amgen received a worldwide exclusive license to Arrowhead’s ARO-LPA RNAi program and an option to a worldwide exclusive license for ARO-AMG1, both for cardiovascular disease.[7]
On Oct. 31, 2018, Arrowhead Pharmaceuticals Inc. closed on a $3.7 billion license and collaboration agreement with Janssen to develop and commercialize ARO-HBV. As part of the deal, Arrowhead entered into a research collaboration and option agreement with Janssen to potentially collaborate for up to three more RNA interference (RNAi) therapeutics against new targets to be selected by Janssen.[8]
^ https://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-reports-fiscal-2022-year-end-results. {{cite web}}: Missing or empty |title= (help)
ArrowheadPharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Farmers Market US Foods Health Care Acadia Healthcare Amedisys ArrowheadPharmaceuticals Azenta Bruker Chemed Corp. Doximity Encompass Health Enovis Envista...
Corporation. In November 2021, Regal Rexnord closes on $297M acquisition of Arrowhead Systems LLC, which has Wisconsin operations in Randolph and Oshkosh. In...